Social Media Ideas for Car-T

Latest updates for Car-T

Fresh curated links around CAR-T are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

genengnews.com /2 weeks ago

Circio’s circVec and Tcelltech’s nanoSMAR Technologies Combined to Generate Nextgen In vivo CAR-T and TCR-T Cells

Circio and Tcelltech will combine Circio's circVec circular RNA expression technology with Tcelltech's non-viral, high-cargo capacity nanoSMAR vector platform and evaluate the comb...

Read source

genengnews.com /1 month ago

Cytokine‑Armored CAR T Cells Overcome Antigen Heterogeneity in Glioma Model

Scientists developed a cytokine-armored CAR T-cell therapy that helps the immune system better attack aggressive brain tumors in mice, which they paired with a CAR T strategy targe...

Read source

bioengineer.org /1 month ago

Key CAR-T Cell Traits Trigger Myeloid Activation

In a groundbreaking study that could redefine the landscape of cellular immunotherapy, researchers have delved deep into the molecular and cellular dynamics underpinning CAR-T cell...

Read source

bioengineer.org /2 weeks ago

CAR T Cell Therapy Targets Crucial Mutation Behind Rare Blood Cancers

A groundbreaking advancement in cancer immunotherapy has emerged from collaborative research led by scientists at University College London (UCL) and the University of Oxford, who...

Read source

fightaging.org /2 weeks ago

CAR-T Cells Can Target Circulating TNF to Product Lasting Control of Autoimmune Conditions

The challenge inherent in present approaches to reduce unwanted inflammation and immune activation, such as by targeting circulating tumor necrosis factor (TNF) with monoclonal ant...

Read source

genengnews.com /2 weeks ago

Intravesical CAR T-Cell Therapy Reduces Bladder Cancer Growth in Preclinical Model

Researchers identified the protein MUC16 as a clinically relevant target for bladder cancer, and engineered MUC16-targeting CAR T cells that, when delivered into the bladder via a...

Read source

singularityhub.com /5 days ago

CAR T Revolutionized How We Treat Blood Cancers. Now It’s Closing In on Solid Tumors.

Separate teams discovered the same target in solid cancers, enabling a powerful two-pronged attack on both tumors and the cells shielding them. The post CAR T Revolutionized How We...

Read source

fiercebiotech.com /2 weeks ago

China approved the world’s first solid tumor CAR-T therapy. When will the US follow?

CAR-T cell therapy has flourished since it was first used in 2010, leading to eight approved medicines for different blood cancers. But adapting the powerful technique, which invol...

Read source

neurosciencenews.com /2 weeks ago

CAR-T Cell Therapy Eradicates Glioblastoma

A new study demonstrates a new CAR-T cell therapy that targets the GPNMB protein found on both glioblastoma cells and tumor-supporting macrophages.

Read source

fiercebiotech.com /1 month ago

Has Novartis’ T-Charge been overtaken by in vivo CAR-Ts? Execs argue there’s room for both

It’s been more than four years since Novartis shook up the CAR-T space with its T-Charge platform. But that’s a lifetime in the fast-moving world of cell therapies.

Read source

fiercebiotech.com /2 weeks ago

Moderna enters in vivo CAR-T, granting autoimmune asset ‘007’ license to kill pathogenic cells

Moderna has unveiled its first in vivo CAR-T program. Building on other groups’ ex vivo CAR-T data, the company plans to start clinical development of an off-the-shelf autoimmune d...

Read source

fiercebiotech.com /1 month ago

‘It looks like this hypothesis will pan out’: Cullinan unveils data building case for autoimmune TCEs

When it comes to turning T-cell therapies toward autoimmune diseases, CAR-Ts have been leading the way. But another red-hot modality is also beginning to show potential in the clin...

Read source

labiotech.eu /4 weeks ago

Eight in vivo CAR T biotechs to follow closely

We have curated a list of in vivo CAR T biotechs in preclinical and clinical stages that you should keep an eye out for. The post Eight in vivo CAR T biotechs to follow closely ...

Read source

aacr.org /1 month ago

Bloodlines Series: CAR T-cell Therapy Shows Promise for Smoldering Myeloma

An immunotherapy typically used in advanced stages of multiple myeloma may be effective against an early form of the disease known as smoldering myeloma—offering a potential new op...

Read source

qchron.com /1 month ago

From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma

SHANGHAI, May 24, 2026 /PRNewswire/ -- A 36-year-old Pakistani patient has achieved encouraging early recovery after receiving personalized CAR-T immunotherapy at Jiahui Internatio...

Read source

kyrgyzstannews.net /1 month ago

Beyond Borders: ImmunoACT and India's Emergence as one of the World's Most Accessible CAR-T Destination

VMPLNew Delhi [India], April 29: A patient from Mauritius with relapsed aggressive non-Hodgkin's lymphoma travelled to India for an indigenously manufactured CAR-T cell therapy by...

Read source

kevinmd.com /2 weeks ago

CAR-T therapy can cure cancer. Why is it so underused?

Imagine a cancer therapy that literally poked holes in cancer cells, destroying them. Imagine that this therapy was approved by the federal Food and Drug Administration and was ava...

Read source

scitechdaily.com /1 month ago

Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer

A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a break...

Read source

fiercebiotech.com /1 month ago

Caribou boosts case that off-the-shelf CAR-T matches autologous drugs ahead of phase 3

Caribou Biosciences has linked its CAR-T cell therapy candidate to 17.1-month median progression-free survival, adding to evidence that the off-the-shelf treatment can match the ef...

Read source

qchron.com /1 month ago

Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer P...

SHANGHAI, May 31, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that...

Read source

wired.com /1 month ago

Supercharging Immune Cells May Help Control HIV Long-Term

CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV.

Read source

fiercebiotech.com /1 week ago

Fate’s off-the-shelf CAR-T therapy shows early promise in treatment-resistant autoimmune disease

“We were not expecting to see clinical responses so early,” Vaneet Sandhu, M.D., rheumatologist and vice president of clinical development at Fate Therapeutics, told Fierce.

Read source

rnz.co.nz /1 month ago

NZ cancer patient travels to Australia for CAR-T therapy, not funded in New Zealand

After exhausting all his options in New Zealand, Tawhai Reti was forced to leave his children behind and make a last-chance dash across the ditch to receive lifesaving treatment.

Read source

qchron.com /1 month ago

ASCO 2026 | Oricell's GPC3 CAR-T Ori-C101 Hits 66.7% ORR in Late-Line HCC, Signaling Best-in-Class Potential

CHICAGO, May 31, 2026 /PRNewswire/ -- Oricell Therapeutics, a clinical-stage biotech company pioneering cancer immunotherapy, today announced that its lead asset, Ori-C101, a GPC3-...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.